| Literature DB >> 32549095 |
Cauê Padovani1, Regiane Maria da Costa Arruda1, Luciana Maria Malosá Sampaio1.
Abstract
OBJECTIVE: To compare the incidence of postoperative complications (PC) between diabetic and nondiabetic patients undergoing cardiovascular surgeries (CS).Entities:
Keywords: Cardiovascular Diseases; Cardiovascular Surgical Procedures; Diabetes Mellitus; Intensive Care Units; Postoperative Complications
Year: 2020 PMID: 32549095 PMCID: PMC7299576 DOI: 10.21470/1678-9741-2019-0027
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Demographic baseline characteristics of diabetic and nondiabetic patients.
| Variables | Diabetic | Nondiabetic (n=188) | Total | |
|---|---|---|---|---|
| Gender, male, n (%) | 63 (63) | 120 (64) | 184 (64) | 0.866 |
| Age (years), median (IQ 25% to 75%) | 66 (61-74) | 68 (59-75) | 67 (60-75) | 0.843 |
| Length of ICU stay (days), median (IQ 25% to 75%) | 4 (3-6) | 3 (3-5) | 4 (3-5) | 0.075 |
ICU=intensive care unit; IQ=interquartile range
Fig. 1Incidence of diabetes mellitus and other cardiovascular risk factors.
Surgical procedures performed (n=288).
| Surgeries | Values |
|---|---|
| Coronary artery bypass grafting, n (%) | 114 (39.6) |
| Vascular surgeries, n (%) | 174 (60.4) |
| Angioplasty and grafting of lower limbs, n (%) | 56 (19.4) |
| Correction of aortic or lower limb aneurysm, n (%) | 42 (14.6) |
| Carotid endarterectomy, n (%) | 31 (10.8) |
| Lower limb amputation, n (%) | 20 (6.9) |
| Thromboembolectomy of lower limbs, n (%) | 16 (5.6) |
| Others, n (%) | 9 (3.1) |
Vasoactive drugs (n=288).
| Variables | Values |
|---|---|
| Use of vasoactive drugs, yes, n (%) | 273 (95) |
| Types of vasoactive drugs | |
| Dobutamine, n (%) | 242 (84) |
| Noradrenaline, n (%) | 118 (41) |
| Sodium nitroprusside, n (%) | 49 (17) |
| Nitroglycerin, n (%) | 46 (16) |
Comparison between diabetic and nondiabetic patients for the occurrence of postoperative complications.
| Postoperative complication | Diabetic | Nondiabetic (n=188) | Total | |
|---|---|---|---|---|
| Bleeding, n (%) | 8 (8) | 13 (6.9) | 21 (7.3) | 0.736 |
| Atrial fibrillation, n (%) | 5 (5) | 8 (4.2) | 13 (4.5) | 0.772 |
| Cardiorespiratory arrest, n (%) | 4 (4) | 6 (3.2) | 10 (3.5) | 0.721 |
| Respiratory complications, n (%) | 5 (5) | 8 (4.2) | 13 (4.5) | 0.772 |
| Abbreviations, acronyms & symbols | |
|---|---|
| ADA | = American Diabetes Association |
| CABG | = Coronary artery bypass grafting |
| CS | = Cardiovascular surgeries |
| HbA1c | = Glycated hemoglobin |
| ICU | = Intensive care unit |
| IQ | = Interquartile range |
| LDL | = Low-density lipoprotein |
| PC | = Postoperative complications |
| SPSS | = Statistical Package for the Social Sciences |
| T2DM | = Type 2 diabetes mellitus |
| WHO | = World Health Organization |
| Author's roles & responsibilities | |
|---|---|
| CP | Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| RMCA | Drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| LMMS | Final approval of the version to be published |